Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 22 | 2024 | 1358 | 5.390 |
Why?
|
| Salmonella | 11 | 2024 | 44 | 4.730 |
Why?
|
| Antineoplastic Agents | 9 | 2017 | 661 | 2.100 |
Why?
|
| Bacterial Proteins | 6 | 2024 | 768 | 1.930 |
Why?
|
| Models, Biological | 11 | 2020 | 1176 | 1.870 |
Why?
|
| Cell Line, Tumor | 20 | 2024 | 1463 | 1.850 |
Why?
|
| Bacteria | 7 | 2024 | 305 | 1.780 |
Why?
|
| Probiotics | 3 | 2022 | 46 | 1.660 |
Why?
|
| Salmonella typhimurium | 6 | 2021 | 84 | 1.640 |
Why?
|
| Genetic Engineering | 6 | 2018 | 116 | 1.480 |
Why?
|
| Colonic Neoplasms | 5 | 2014 | 221 | 1.380 |
Why?
|
| Drug Delivery Systems | 6 | 2021 | 327 | 1.360 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 158 | 1.350 |
Why?
|
| Salmonella enterica | 2 | 2019 | 26 | 1.210 |
Why?
|
| Biological Therapy | 3 | 2018 | 16 | 1.180 |
Why?
|
| Immunotherapy | 4 | 2024 | 257 | 1.160 |
Why?
|
| Green Fluorescent Proteins | 3 | 2023 | 364 | 1.020 |
Why?
|
| Adenocarcinoma | 3 | 2014 | 338 | 1.010 |
Why?
|
| Apoptosis | 7 | 2014 | 1073 | 1.010 |
Why?
|
| Microfluidics | 2 | 2016 | 25 | 0.910 |
Why?
|
| Microscopy, Fluorescence | 8 | 2015 | 400 | 0.890 |
Why?
|
| Microfluidic Analytical Techniques | 4 | 2013 | 25 | 0.860 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2014 | 30 | 0.850 |
Why?
|
| Hemolysin Proteins | 2 | 2014 | 44 | 0.840 |
Why?
|
| Tumor Cells, Cultured | 4 | 2016 | 453 | 0.830 |
Why?
|
| Spheroids, Cellular | 5 | 2016 | 27 | 0.830 |
Why?
|
| Glucose | 3 | 2016 | 467 | 0.810 |
Why?
|
| Intestinal Mucosa | 2 | 2022 | 245 | 0.800 |
Why?
|
| Neoplasms, Experimental | 2 | 2015 | 77 | 0.780 |
Why?
|
| Escherichia coli | 3 | 2021 | 700 | 0.760 |
Why?
|
| Listeria monocytogenes | 1 | 2021 | 34 | 0.730 |
Why?
|
| Mice | 15 | 2024 | 10838 | 0.720 |
Why?
|
| Caspase 3 | 1 | 2021 | 108 | 0.710 |
Why?
|
| Cell Survival | 5 | 2017 | 568 | 0.710 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 644 | 0.700 |
Why?
|
| Humans | 38 | 2024 | 63160 | 0.700 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 614 | 0.700 |
Why?
|
| Cell Culture Techniques | 3 | 2012 | 182 | 0.690 |
Why?
|
| Mucus | 1 | 2020 | 15 | 0.680 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2011 | 83 | 0.670 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 341 | 0.670 |
Why?
|
| Cell Nucleus | 2 | 2023 | 625 | 0.660 |
Why?
|
| Interleukin-8 | 1 | 2020 | 88 | 0.660 |
Why?
|
| Doxorubicin | 4 | 2013 | 99 | 0.650 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 178 | 0.640 |
Why?
|
| Clostridium | 2 | 2010 | 10 | 0.600 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 674 | 0.600 |
Why?
|
| Animals | 18 | 2024 | 20647 | 0.600 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 297 | 0.600 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 198 | 0.560 |
Why?
|
| Necrosis | 3 | 2014 | 143 | 0.550 |
Why?
|
| Viruses | 1 | 2018 | 80 | 0.550 |
Why?
|
| Bacterial Toxins | 2 | 2015 | 61 | 0.530 |
Why?
|
| Cell Proliferation | 5 | 2021 | 980 | 0.500 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 36 | 0.490 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 503 | 0.490 |
Why?
|
| Glutamine | 2 | 2014 | 46 | 0.490 |
Why?
|
| Lactic Acid | 2 | 2014 | 76 | 0.480 |
Why?
|
| Colony Count, Microbial | 4 | 2019 | 60 | 0.480 |
Why?
|
| Salmonella Infections | 2 | 2014 | 42 | 0.480 |
Why?
|
| Models, Theoretical | 2 | 2014 | 268 | 0.470 |
Why?
|
| Quorum Sensing | 1 | 2015 | 6 | 0.470 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 662 | 0.460 |
Why?
|
| Genes, Reporter | 3 | 2013 | 255 | 0.460 |
Why?
|
| Locomotion | 1 | 2015 | 116 | 0.450 |
Why?
|
| Gold | 4 | 2010 | 226 | 0.450 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2014 | 41 | 0.440 |
Why?
|
| Lipid A | 1 | 2014 | 66 | 0.420 |
Why?
|
| Genetic Vectors | 3 | 2021 | 868 | 0.420 |
Why?
|
| Prodrugs | 2 | 2015 | 36 | 0.400 |
Why?
|
| Hypoxia | 1 | 2014 | 115 | 0.400 |
Why?
|
| Lab-On-A-Chip Devices | 3 | 2019 | 23 | 0.400 |
Why?
|
| Biological Transport | 4 | 2017 | 291 | 0.400 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 177 | 0.400 |
Why?
|
| Cell Communication | 1 | 2013 | 130 | 0.380 |
Why?
|
| Antigens, Neoplasm | 2 | 2023 | 135 | 0.370 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2010 | 7 | 0.340 |
Why?
|
| Oncolytic Virotherapy | 2 | 2021 | 6 | 0.340 |
Why?
|
| Gluconeogenesis | 1 | 2010 | 15 | 0.340 |
Why?
|
| Metal Nanoparticles | 2 | 2010 | 186 | 0.330 |
Why?
|
| Cell Hypoxia | 2 | 2007 | 43 | 0.330 |
Why?
|
| Diffusion | 4 | 2015 | 82 | 0.330 |
Why?
|
| Chemotaxis | 2 | 2007 | 49 | 0.320 |
Why?
|
| Genetic Enhancement | 1 | 2008 | 2 | 0.300 |
Why?
|
| Membrane Proteins | 1 | 2014 | 894 | 0.300 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 280 | 0.300 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2008 | 20 | 0.300 |
Why?
|
| Food | 1 | 2008 | 77 | 0.290 |
Why?
|
| Cytokines | 2 | 2022 | 934 | 0.280 |
Why?
|
| Paclitaxel | 1 | 2008 | 99 | 0.270 |
Why?
|
| Chemoreceptor Cells | 1 | 2007 | 4 | 0.270 |
Why?
|
| Ribose | 1 | 2007 | 5 | 0.270 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 189 | 0.270 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 2187 | 0.270 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 36 | 0.260 |
Why?
|
| Energy Metabolism | 2 | 2008 | 379 | 0.260 |
Why?
|
| Biosynthetic Pathways | 1 | 2006 | 18 | 0.260 |
Why?
|
| Polyethylene Glycols | 2 | 2021 | 168 | 0.260 |
Why?
|
| Genome, Bacterial | 1 | 2006 | 67 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 3394 | 0.260 |
Why?
|
| Half-Life | 2 | 2017 | 80 | 0.240 |
Why?
|
| Computer Simulation | 1 | 2008 | 476 | 0.240 |
Why?
|
| Time-Lapse Imaging | 2 | 2016 | 19 | 0.230 |
Why?
|
| Estradiol | 1 | 2006 | 257 | 0.230 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 894 | 0.230 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 40 | 0.230 |
Why?
|
| Inflammation | 2 | 2022 | 1145 | 0.220 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 1143 | 0.220 |
Why?
|
| Tissue Distribution | 1 | 2024 | 293 | 0.220 |
Why?
|
| MCF-7 Cells | 2 | 2014 | 70 | 0.220 |
Why?
|
| Synthetic Biology | 1 | 2023 | 15 | 0.210 |
Why?
|
| Ovalbumin | 1 | 2023 | 116 | 0.210 |
Why?
|
| Mitochondria | 1 | 2006 | 370 | 0.200 |
Why?
|
| Bacteriolysis | 1 | 2021 | 6 | 0.190 |
Why?
|
| Female | 6 | 2024 | 32719 | 0.190 |
Why?
|
| Bacteriological Techniques | 2 | 2015 | 28 | 0.180 |
Why?
|
| Cytoplasm | 1 | 2023 | 276 | 0.180 |
Why?
|
| Adenoviridae | 1 | 2021 | 121 | 0.180 |
Why?
|
| Dendritic Cells | 1 | 2024 | 524 | 0.180 |
Why?
|
| Vaccination | 1 | 2023 | 362 | 0.170 |
Why?
|
| HT29 Cells | 1 | 2020 | 28 | 0.170 |
Why?
|
| Movement | 1 | 2021 | 155 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 195 | 0.160 |
Why?
|
| Clinical Studies as Topic | 1 | 2018 | 1 | 0.150 |
Why?
|
| Cancer Vaccines | 1 | 2018 | 49 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 455 | 0.140 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 97 | 0.140 |
Why?
|
| Glutamic Acid | 2 | 2010 | 100 | 0.140 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 371 | 0.140 |
Why?
|
| Culture Media | 2 | 2008 | 79 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 1199 | 0.140 |
Why?
|
| Treatment Outcome | 2 | 2018 | 5621 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 298 | 0.130 |
Why?
|
| Fibroblasts | 2 | 2010 | 387 | 0.130 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2016 | 13 | 0.130 |
Why?
|
| Amino Acids | 2 | 2008 | 146 | 0.130 |
Why?
|
| Bacterial Vaccines | 1 | 2016 | 87 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 861 | 0.120 |
Why?
|
| Microscopy, Video | 1 | 2015 | 38 | 0.120 |
Why?
|
| Methyl-Accepting Chemotaxis Proteins | 1 | 2014 | 2 | 0.120 |
Why?
|
| Selection, Genetic | 1 | 2015 | 83 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2023 | 1513 | 0.110 |
Why?
|
| Carbohydrates | 1 | 2014 | 40 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 62 | 0.110 |
Why?
|
| Kinetics | 2 | 2014 | 761 | 0.110 |
Why?
|
| Cell Shape | 1 | 2014 | 12 | 0.110 |
Why?
|
| Child | 1 | 2023 | 4517 | 0.110 |
Why?
|
| Nanostructures | 2 | 2006 | 178 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 233 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2014 | 307 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2014 | 185 | 0.100 |
Why?
|
| Arabinose | 1 | 2013 | 4 | 0.100 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 700 | 0.100 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 128 | 0.100 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 383 | 0.090 |
Why?
|
| Plasmids | 1 | 2013 | 291 | 0.090 |
Why?
|
| Bacterial Adhesion | 2 | 2021 | 63 | 0.090 |
Why?
|
| Male | 4 | 2021 | 29721 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 1997 | 0.090 |
Why?
|
| Algorithms | 2 | 2007 | 1001 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 140 | 0.090 |
Why?
|
| Particle Size | 2 | 2010 | 407 | 0.090 |
Why?
|
| Malate Dehydrogenase | 1 | 2010 | 3 | 0.080 |
Why?
|
| Tricarboxylic Acids | 1 | 2010 | 2 | 0.080 |
Why?
|
| Least-Squares Analysis | 1 | 2010 | 24 | 0.080 |
Why?
|
| Fluorescein | 1 | 2010 | 13 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1643 | 0.080 |
Why?
|
| Anions | 1 | 2010 | 33 | 0.080 |
Why?
|
| Isotope Labeling | 1 | 2010 | 70 | 0.080 |
Why?
|
| Oxygen | 1 | 2012 | 315 | 0.080 |
Why?
|
| Cations | 1 | 2010 | 64 | 0.080 |
Why?
|
| Biomarkers | 1 | 2015 | 1392 | 0.080 |
Why?
|
| Light | 2 | 2008 | 202 | 0.080 |
Why?
|
| Acridine Orange | 1 | 2008 | 4 | 0.080 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 36 | 0.080 |
Why?
|
| Phantoms, Imaging | 1 | 2010 | 214 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2008 | 125 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2008 | 188 | 0.070 |
Why?
|
| Equipment Design | 1 | 2008 | 345 | 0.070 |
Why?
|
| Receptors, Amino Acid | 1 | 2007 | 2 | 0.070 |
Why?
|
| Carbon Isotopes | 1 | 2006 | 17 | 0.060 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2007 | 87 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 321 | 0.060 |
Why?
|
| Luciferases | 1 | 2006 | 107 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 113 | 0.060 |
Why?
|
| Glutathione | 1 | 2006 | 54 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2008 | 389 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 228 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 296 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2006 | 209 | 0.060 |
Why?
|
| DNA | 2 | 2008 | 830 | 0.060 |
Why?
|
| Cell Death | 1 | 2006 | 284 | 0.060 |
Why?
|
| Mice, Inbred C3H | 1 | 2003 | 176 | 0.050 |
Why?
|
| Cell Line | 1 | 2007 | 2036 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2003 | 520 | 0.050 |
Why?
|
| Chemokine CCL2 | 1 | 2021 | 57 | 0.050 |
Why?
|
| Liposomes | 1 | 2021 | 107 | 0.050 |
Why?
|
| Swimming | 1 | 2021 | 27 | 0.040 |
Why?
|
| Monocytes | 1 | 2021 | 353 | 0.040 |
Why?
|
| Hydrogels | 1 | 2021 | 115 | 0.040 |
Why?
|
| Mutation | 1 | 2007 | 2608 | 0.040 |
Why?
|
| Scattering, Radiation | 1 | 2008 | 73 | 0.020 |
Why?
|
| COS Cells | 1 | 2008 | 174 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 457 | 0.020 |
Why?
|
| Photochemistry | 1 | 2006 | 24 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2006 | 114 | 0.010 |
Why?
|
| Nanotechnology | 1 | 2006 | 135 | 0.010 |
Why?
|
| Drug Carriers | 1 | 2006 | 179 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 1332 | 0.010 |
Why?
|